Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05341544 · ClinicalTrials.gov registry record · NA

Non-invasive Vagal Stimulation for Frequent Premature Ventricular Complexes

A NA study of Premature Ventricular Contraction, sponsored by Northwell Health.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT05341544: Recruiting NA study of Premature Ventricular Contraction, sponsored by Northwell Health.

NCT05341544 is a NA study of Premature Ventricular Contraction that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05341544, a NA study of Premature Ventricular Contraction, is actively recruiting participants, sponsored by Northwell Health.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

A prospective sham-controlled randomized clinical trial to assess the effect of low-level tragus stimulation (LLTS) in patients with frequent premature ventricular complexes (PVCs)

Primary Outcome

Daily PVC Count by event monitor

Interventions

  • DEVICE Sham device
  • DEVICE Parasym device

Study Locations (2)

New York

  • Northwell Health - New York

Oklahoma

  • University of Oklahoma Health Sciences Center - Oklahoma City

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-08-22
Est. Completion 2025-12-22
Phase NA
Northwell Health

370 total trials

What NCT05341544 shows while recruiting

NCT05341544 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Premature Ventricular Contraction appearing as the primary indexed condition, and to 2 interventions - of which Sham device is the first listed.

NCT05341544 reports a single indexed study location in New York, Oklahoma.

Frequently Asked Questions

What is clinical trial NCT05341544 about?

NCT05341544 is a clinical study titled "Non-invasive Vagal Stimulation for Frequent Premature Ventricular Complexes". A prospective sham-controlled randomized clinical trial to assess the effect of low-level tragus stimulation (LLTS) in patients with frequent premature ventricular complexes (PVCs)

What is the current status of trial NCT05341544?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-08-22. Estimated completion is 2025-12-22.

What conditions does trial NCT05341544 study?

This clinical trial studies the following conditions: Premature Ventricular Contraction.

What interventions are being tested in trial NCT05341544?

The interventions under investigation include: Sham device (DEVICE), Parasym device (DEVICE).

Who is sponsoring clinical trial NCT05341544?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05341544 being conducted?

This trial has 2 study locations across New York, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Premature Ventricular Contraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05341544's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05341544, the US trial registry maintained by the National Library of Medicine. NCT05341544 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.